Company Directory - Research & Development
Antibody Analytics are specialists in primary cell method development and analysis, dedicated to advancing drug development. From discovery to the later clinical stages, we know how to build the correct assay designs at the appropriate stage to provide meaningful information to you and your team.
Antikor Ltd is a newly established company that is exploiting a novel technology platform called OptiLinked-FDCs, to generate revolutionary products to treat solid cancers. We are a multidisciplinary spin-out from Imperial College London UK now based at the Stevenage Bioscience Catalyst.
Antisense Therapeutics is an Australian publicly-listed biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The products are in-licensed from Ionis Pharmaceuticals Inc. (NASDAQ: IONS), an established leader in antisense drug development.
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease.
Aqilion is a biotech company that focuses on developing new innovative treatments for diseases caused by chronic inflammation and dysfunctional immune reactions such as autoimmune diseases. The company is mainly active in the early phases of drug discovery, from idea to early clinical development.
Arcus was founded in 2015 with the vision of bringing together scientists, physicians, advisors, and other leaders with significant content-matter expertise to focus on developing highly combinable, best-in-class cancer therapies.
Arranta’s vision is to be the trusted and innovative CDMO partner for advanced therapy pioneers so that together we can bring life-changing therapeutics to patients.
We are driven to bring new solutions to people living with CNS disorders. We aspire to do this by making innovative therapies available to all who need them. Arvelle Therapeutics is a company of the Angelini Pharma group.
Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune, and viral diseases. We utilize T‑Cells from donors with healthy immune function, with the goal to specifically recognize and target cancerous or diseased cells in patients without affecting normal cells.
We focus on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT) and other neuromuscular diseases. The company is rooted in the ground-breaking research at VIB and KU Leuven and supported by V-Bio Ventures, PMV, Advent France Biotechnology and Gemma Frisius Fund.
Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer.
Avidity Biosciences is pioneering a new class of oligonucleotide-based therapies called AOCs designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases.
Awakn Life Sciences is a biotechnology company with clinical operations researching, developing, and delivering psychedelic new chemical entity drugs and therapies to treat Addiction. We are integrating psychedelic medicine into mainstream healthcare to enable better mental health for more people through Research, Digital, Clinics, and Ecosystems.
We offer the best solutions for today and are relentlessly developing innovation for tomorrow. We are passionate and dedicated to support our customers in discovering breakthrough medical advances that will significantly improve the life of patients. As partners we work hand in hand.
Bavarian Nordic is a fully integrated biotechnology company focused on the development of innovative therapies against infectious diseases and cancer.
Beckley Psytech is dedicated to helping patients suffering from neurological and psychiatric disorders by developing a pipeline of psychedelic compounds into licensed pharmaceutical medicines.
Berlin Cures Holding AG is a spin-off company founded in September 2014 in order to bring a successful research project to the market. A group of scientists from the Max Delbrück Center (MDC), the Charité Berlin and the German Heart Institute Berlin has been studying the significance of autoantibodies in heart disease and other autoimmune diseases for over 10 years.
Besins Healthcare is a world leader in novel therapies for gynaecology and andrology. We have discovered ground-breaking technologies to improve patient well-being throughout our history. Our products are trusted and prescribed by healthcare professionals in more than 100 countries throughout the world.
